Facilitated By

San Antonio Medical Foundation

MIF Inhibition as a novel treatment for autoimmune myocarditis

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Thomas Forsthuber
Funded by
Natl Inst of Health
Research Start Date
Status
Active
Collaborative Project
Basic Research
Drug Discovery
Cardiovascular